Abstract
Ketamine (KET) exhibits potential anticancer activity, with enhanced cytotoxicity against melanoma cells when combined with the permeation enhancer dodecyl maltoside (DDM). To support clinical translation, this study evaluated the embryotoxicity, effects on angiogenesis, and cytocompatibility of KET, DDM, and their combination (KET + DDM) using a chicken embryo model. The chorioallantoic membrane (CAM) assay was used to assess angiogenesis following treatment with KET (1000 µM), DDM (19.6 µM), or KET + DDM in fertilized eggs. Embryonic survival and morphology were monitored for five days. Quantitative PCR analysis of heart, lung, kidney, and brain tissues evaluated apoptosis-related genes (Caspase 3, Caspase 8, Caspase 9, BAX) and VEGF expression. Cytocompatibility was examined in primary embryonic fibroblasts (EFBs) using AlamarBlue assays and morphological assessment. The results showed no significant differences in vascular density, vessel length, or branching in the CAM assay across all treatments. Embryos treated with KET or KET + DDM showed normal survival and morphology, while DDM alone reduced viability. Apoptotic and angiogenic gene expression remained unchanged in major organs. In vitro, KET and KET + DDM did not reduce EFB viability or alter morphology. Overall, KET and KET + DDM did not produce detectable adverse effects in embryonic and cellular models, preserving angiogenesis and development. Notably, the KET + DDM combination showed no detectable adverse effects, supporting the preliminary safety of this combination for further anticancer investigation.
Data availability
Data is provided within the manuscript.
References
Saito, J. et al. Anti-cancer effect of ketamine in comparison with MK801 on neuroglioma and lung cancer cells. Eur. J. Pharmacol. ;945(175580). (2023).
Zhou, X. et al. Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69. Cancer Med. 7 (3), 788–795 (2018).
He, G. N. et al. Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1/miR-214-3p/GPX4. Drug Des. Devel Ther. 15, 3965–3978 (2021).
Zhao, S., Shao, L., Wang, Y., Meng, Q. & Yu, J. Ketamine exhibits anti-gastric cancer activity via induction of apoptosis and attenuation of PI3K/Akt/mTOR. Arch. Med. Sci. 16 (5), 1140–1149 (2019).
Li, H. et al. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis. Biochem. Biophys. Res. Commun. [Internet]. 585, 111–116. (2021). Available from: https://doi.org/10.1016/j.bbrc.2021.11.029
Malsy, M. et al. Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells. BMC Anesthesiol [Internet]. 15(1), 1–7. (2015). Available from: https://doi.org/10.1186/s12871-015-0076-y
Niwa, H., Furukawa, K. I., Seya, K. & Hirota, K. Ketamine suppresses the proliferation of rat C6 glioma cells. Oncol. Lett. 14 (4), 4911–4917 (2017).
Idoudi, S. et al. Ketamine and dodecyl maltoside synergy as a potential topical therapeutic approach for melanoma. Sci. Reports [Internet]. 15(1), 37887 Available from: https://www.nature.com/articles/s41598-025-21668-1
Gholizadeh, A., Amjad-Iranagh, S. & Halladj, R. Assessing the Interaction between Dodecylphosphocholine and Dodecylmaltoside Mixed Micelles as Drug Carriers with Lipid Membrane: A Coarse-Grained Molecular Dynamics Simulation. ACS Omega [Internet]. (2024). https://pubs.acs.org/doi/full/10.1021/acsomega.4c02551
Petersen, S. B. et al. Evaluation of alkylmaltosides as intestinal permeation enhancers: Comparison between rat intestinal mucosal sheets and Caco-2 monolayers. Eur. J. Pharm. Sci. 47 (4), 701–712 (2012).
Yu, Y. Q., Yang, X., Wu, X. F., Fan, Y. & Bin Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications. Front. Bioeng. Biotechnol. 9, 646554 (2021).
Larsen, N. W. et al. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments. Int. J. Pharm. 654, 123957 (2024).
Aguirre-Ramírez, M., Silva-Jiménez, H., Banat, I. M. & Díaz De Rienzo, M. A. Surfactants: physicochemical interactions with biological macromolecules. Biotechnol Lett. [Internet]. 43(3), 523. https://pmc.ncbi.nlm.nih.gov/articles/PMC7872986/
Tirumalasetty, P. P. & Eley, J. G. Evaluation of Dodecylmaltoside as a Permeability Enhancer for Insulin Using Human Carcinoma Cells. J. Pharm. Sci. 94 (2), 246–255 (2005).
Michael Danielsen, E. & Hansen, G. H. Probing the Action of Permeation Enhancers Sodium Cholate and N-dodecyl-β-D-maltoside in a Porcine Jejunal Mucosal Explant System. Pharm. 10(4), 172. (2018). https://www.mdpi.com/1999-4923/10/4/172/htm
Gradauer, K. et al. Dodecylmaltoside Modulates Bicellular Tight Junction Contacts to Promote Enhanced Permeability. Mol. Pharm. [Internet]. 14(12), 4734–4740. https://pubs.acs.org/doi/abs/https://doi.org/10.1021/acs.molpharmaceut.7b00297
Zhang, T., Li, M., Han, X., Nie, G. & Zheng, A. Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride. AAPS PharmSciTech ;23(5), 143 PMID: 35578146. doi: 10.1208/s12249-022-02252-6 (2022).
Xia, Y. et al. Performance and toxicity of different absorption enhancers used in the preparation of Poloxamer thermosensitive in situ gels for ketamine nasal administration. Drug Dev Ind Pharm [Internet]. May 3 [cited 2024 Jan 2];46(5):697–705. Available from: https://www.tandfonline.com/doi/abs/ (2020). https://doi.org/10.1080/03639045.2020.1750625
Steyn, J. D. et al. Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models. Pharm [Internet]. 18(2), 195. https://www.mdpi.com/1424-8247/18/2/195/htm
Crasta, A. et al. Transdermal drug delivery system: A comprehensive review of innovative strategies, applications, and regulatory perspectives. OpenNano 24, 100245 (2025).
Lugano, R., Ramachandran, M. & Dimberg, A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol. Life Sci. C [Internet]. 77(9), 1745. (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC7190605/
Pathak, A., Pal, A. K., Roy, S., Nandave, M. & Jain, K. Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies. Stem Cells Int. [Internet]. 2024(1), 9077926. (2024) https://onlinelibrary.wiley.com/doi/full/https://doi.org/10.1155/2024/9077926
Liu, Z. L., Chen, H. H., Zheng, L. L., Sun, L. P. & Shi, L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther [Internet]. 8(1), 198. (2023) https://www.nature.com/articles/s41392-023-01460-1
Goel, S. et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. [Internet]. 91(3), 1071. (2011). https://pmc.ncbi.nlm.nih.gov/articles/PMC3258432/
Dudley, A. C. & Griffioen, A. W. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenes [Internet]. 26(3), 313–347. (2023) https://link.springer.com/article/https://doi.org/10.1007/s10456-023-09876-7
Nowak-Sliwinska, P., Segura, T. & Iruela-Arispe, M. L. The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis [Internet]. 17(4), 779. (2014). Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4583126/
Dhayer, M. et al. Implementing Chicken Chorioallantoic Membrane (CAM) Assays for Validating Biomaterials in Tissue Engineering: Rationale and Methods. J. Biomed. Mater Res. Part B Appl. Biomater [Internet]. 112(11), e35496. (2025) https://onlinelibrary.wiley.com/doi/full/https://doi.org/10.1002/jbm.b.35496
Kue, C. S., Tan, K. Y., Lam, M. L. & Lee, H. B. Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs. Exp Anim [Internet]. 64(2), 129. (2026) https://pmc.ncbi.nlm.nih.gov/articles/PMC4427727/
Yuan, Y. J., Xu, K., Wu, W., Luo, Q. & Yu, J. L. Application of the Chick Embryo Chorioallantoic Membrane in Neurosurgery Disease. Int. J. Med. Sci. [Internet]. 11(12), 1275–1281. (2014). http://www.medsci.org1275
Butler, K. S., Brinker, C. J. & Leong, H. S. Bridging the in Vitro to in Vivo gap: Using the Chick Embryo Model to Accelerate Nanoparticle Validation and Qualification for in Vivo studies. ACS Nano [Internet]. 16(12), 19626–19650. https://pubs.acs.org/doi/full/https://doi.org/10.1021/acsnano.2c03990
Fischer, D. et al. The CAM Model—Q&A with Experts. Cancers [Internet]. 15(1), 191. https://www.mdpi.com/2072-6694/15/1/191/htm
Tazawa, H. Adverse effect of failure to turn the avian egg on the embryo oxygen exchange. Respir Physiol. 41 (2), 137–142 (1980).
Kheraldine, H. et al. Naked Poly(amidoamine) Dendrimer Nanoparticles Exhibit Intrinsic Embryotoxicity During the Early Stages of Normal Development. J. Biomed. Nanotechnol. [Internet]. 16(10), 1454–62. (2020) https://nchr.elsevierpure.com/en/publications/naked-polyamidoamine-dendrimer-nanoparticles-exhibit-intrinsic-em/fingerprints/
Zudaire, E., Gambardella, L., Kurcz, C. & Vermeren, S. A Computational Tool for Quantitative Analysis of Vascular Networks. PLoS One [Internet]. 6(11), e27385. (2011). https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0027385
Kheraldine, H. et al. Effects of neratinib on angiogenesis and the early stage of the embryo using chicken embryo as a model. Biomol. Biomed. [Internet]. 24(3), 575–81. (2024). https://pubmed.ncbi.nlm.nih.gov/38158791/
Al-Asmakh, M. et al. Dasatinib and PD-L1 inhibitors provoke toxicity and inhibit angiogenesis in the embryo. Biomed. Pharmacother. 134, 111134 (2021).
Palumbo, C., Sisi, F., Checchi, M. CAM Model: Intriguing Natural Bioreactor for Sustainable Research and Reliable/Versatile Testing. Biol. [Internet]. 12(9), 1219. (2023). https://www.mdpi.com/2079-7737/12/9/1219/htm
Yıldırım, A. K., Özgürtaş, E. & İnce, M. E. Anti-angiogenic response of ketamine in the in vitro and in vivo settings. Turkish J. Vasc Surg. 31 (2), 67–71 (2022).
Waschkies, C., Nicholls, F. & Buschmann, J. Comparison of medetomidine, thiopental and ketamine/midazolam anesthesia in chick embryos for in ovo Magnetic Resonance Imaging free of motion artifacts. Sci. Rep. 5 (April), 1–6 (2015).
Lee, C. et al. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther 10(1), 170. (2025) https://www.nature.com/articles/s41392-025-02249-0
Zhao, Y. & Lu, H. A comprehensive description of VEGF-R1/2 small molecule inhibitors as anticancer agents. Bioorg. Chem. 166, 109159 (2025).
Li, Y., Li, J., Zhang, X., Ding, J. & Mao, S. Non-ionic surfactants as novel intranasal absorption enhancers: in vitro and in vivo characterization. Drug Deliv. 23 (7), 2272–2279 (2016).
Hmingthansanga, V. et al. Improved Topical Drug Delivery: Role of Permeation Enhancers and Advanced Approaches. Pharmaceutics [Internet]. 14(12), 2818. https://pmc.ncbi.nlm.nih.gov/articles/PMC9785322/
Wang, Y. et al. Exploring the effects of different types of surfactants on zebrafish embryos and larvae. Sci. Rep. ;5, 10107; doi: 10.1038/srep10107 (2015).
Félix, L. M. et al. Embryonic Stage-Dependent Teratogenicity of Ketamine in Zebrafish (Danio rerio). Chem. Res. Toxicol. 29 (8), 1298–1309 (2016).
Guo, R. et al. Early ketamine exposure results in cardiac enlargement and heart dysfunction in Xenopus embryos. BMC Anesthesiol [Internet]. 16(1), 1–8. (2016). https://doi.org/10.1186/s12871-016-0188-z
Sedlacek, J. Influence of ketamine on the spontaneous motility of chick embryos and its development. Physiol. Res. 41 (6), 445–449 (1992).
Acknowledgements
The authors gratefully acknowledge the financial support and Open Access funding provided by Qatar University. The authors also thank Mazzraty Poultry, Qatar, for their support in providing and delivering fertilized eggs. In addition, the authors acknowledge the Biomedical Research Center (BRC), Qatar University, for providing the necessary facilities to conduct this work.
Funding
Dr. Alkilany’s Laboratory is supported by funding from Qatar University and the Qatar Research, Development, and Innovation (QRDI) Council. Open Access funding is provided by Qatar University.
Author information
Authors and Affiliations
Contributions
S.I.: Data curation, Formal analysis, Writing—original draft. H.K.: Data curation, Formal analysis. A.H.F.: Data curation, Formal analysis. L.A.: Supervision, Writing—review and editing. K.A.A.: Supervision, Writing—review and editing. H.A.: Supervision, Writing—review and editing. A.E.: Supervision, Writing—review and editing. O.R.: Supervision, Writing—review and editing. A.M.A.: Conceptualization, Main supervision, Validation, Funding acquisition, Methodology, Project administration, Resources, Writing—review and editing. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Idoudi, S., Hassan, A.F., Kheraldine, H. et al. Safety evaluation of a ketamine–dodecyl maltoside combination using angiogenesis and embryonic development models. Sci Rep (2026). https://doi.org/10.1038/s41598-026-46828-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-46828-9
